From our private database of 14,200+ case briefs...
Matrixx Initiatives v. Siracusano
United States Supreme Court
131 S.Ct. 1309 (2011)
Matrixx Initiatives, Inc. (Matrixx) (defendant) manufactures and sells the product Zicam, a nasal spray and gel designed to combat the common cold. Beginning in 1999, Zicam received reports of a possible link between Zicam nasal spray and anosmia, which is the loss of the sense of smell. By September 2002, Matrixx had received several complaints from Zicam consumers who developed anosmia, and had hired a consultant to look into the issue. Matrixx also received case studies of Zicam consumers suffering from anosmia. In late 2003, Matrixx was sued by plaintiffs who alleged they lost their sense of smell after using Zicam. During the relevant period, Matrixx issued a series of statements indicating that Zicam would have high earnings. At no time did Matrixx disclose the adverse reports of anosmia or the existence of anosmia-related lawsuits. In response to publicity about the possible link between Zicam and anosmia, Matrixx called such allegations unfounded. A class of Matrixx investors who purchased stock between October 22, 2003, and February 6, 2004 sued Matrixx, claiming that Matrixx made misleading statements by failing to disclose reports that users of Zicam nasal spray suffered from anosmia. The District Court dismissed the complaint, reasoning that the plaintiffs failed to show that Matrixx had received a statistically significant number of adverse reports, such that Matrixx would have been required to disclose them. The District Court also held that the plaintiffs did not allege facts that led to a strong inference of scienter. The Court of Appeals for the Ninth Circuit reversed, stating that statistical significance was not required. It also found that Matrixx’s withholding of adverse reports gave rise to a strong inference of scienter. This Court granted certiorari.
Rule of Law
Holding and Reasoning (Sotomayor, J.)
What to do next…
Unlock this case brief with a free (no-commitment) trial membership of Quimbee.
You’ll be in good company: Quimbee is one of the most widely used and trusted sites for law students, serving more than 97,000 law students since 2011. Some law schools—such as Yale, Vanderbilt, Berkeley, and the University of Illinois—even subscribe directly to Quimbee for all their law students. Read our student testimonials.
Learn more about Quimbee’s unique (and proven) approach to achieving great grades at law school.
Quimbee is a company hell-bent on one thing: helping you get an “A” in every course you take in law school, so you can graduate at the top of your class and get a high-paying law job. We’re not just a study aid for law students; we’re the study aid for law students. Read more about Quimbee.
Here's why 237,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 14,200 briefs, keyed to 189 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.